153 related articles for article (PubMed ID: 9825716)
1. Treating advanced prostate cancer.
Health News; 1998 Nov; 4(14):7. PubMed ID: 9825716
[No Abstract] [Full Text] [Related]
2. Combined castration and androgen blockade therapy in prostate cancer. Conclusions.
Denis L; Mettlin C
Cancer; 1990 Sep; 66(5 Suppl):1086-9. PubMed ID: 2203520
[No Abstract] [Full Text] [Related]
3. [Treatment of advanced prostate cancer].
Leisinger HJ; Jichlinski P
Rev Med Suisse Romande; 1999 Jun; 119(6):507-11. PubMed ID: 10422478
[No Abstract] [Full Text] [Related]
4. [Cancer of the prostate. What treatment, for which patient, in 1986?].
Boccon-Gibod L
Ann Urol (Paris); 1986; 20(2):79-81. PubMed ID: 3717903
[No Abstract] [Full Text] [Related]
5. Hormonal management of advanced adenocarcinoma of the prostate.
Miles BJ
Henry Ford Hosp Med J; 1989; 37(1):16-8. PubMed ID: 2670839
[No Abstract] [Full Text] [Related]
6. Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.
Foote JE; Crawford ED
Semin Urol; 1988 Nov; 6(4):291-302. PubMed ID: 3068767
[No Abstract] [Full Text] [Related]
7. A critical review of the concept of total androgen ablation in the treatment of prostate cancer.
Schulze H; Isaacs JT; Coffey DS
Prog Clin Biol Res; 1987; 243A():1-19. PubMed ID: 3309968
[No Abstract] [Full Text] [Related]
8. [Therapy of advanced prostate cancer].
Langkopf B
Z Urol Nephrol; 1987 Mar; 80(3):121-4. PubMed ID: 3111121
[TBL] [Abstract][Full Text] [Related]
9. [Review of phase III clinical trials on combined anti-androgen therapies in patients with metastasized prostatic cancer].
Denis L; Dalesio O; Murphy G
Prog Urol; 1993 Feb; 3(1):75-85. PubMed ID: 8485599
[No Abstract] [Full Text] [Related]
10. Combined androgen blockade: an update.
Klotz L
Urol Clin North Am; 2006 May; 33(2):161-6, v-vi. PubMed ID: 16631454
[TBL] [Abstract][Full Text] [Related]
11. Anemia in patients on combined androgen block therapy for prostate cancer.
Qian LX; Hua LX; Wu HF; Sui YG; Cheng SG; Zhang W; Li J; Wang XR
Asian J Androl; 2004 Dec; 6(4):383-4. PubMed ID: 15546035
[TBL] [Abstract][Full Text] [Related]
12. Update of EORTC clinical trials in prostate cancer. The EORTC Genito-Urinary Group.
Newling DW; Pavone Macaluse M; Smith P; de Voogt HJ; Robinson MR; Schroder FH; Denis L; Jones WG; de Pauw M; Sylvester R
Semin Urol; 1992 Feb; 10(1):65-71. PubMed ID: 1565905
[No Abstract] [Full Text] [Related]
13. Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
Palmberg C; Koivisto P; Kakkola L; Tammela TL; Kallioniemi OP; Visakorpi T
J Urol; 2000 Dec; 164(6):1992-5. PubMed ID: 11061898
[TBL] [Abstract][Full Text] [Related]
14. [First line therapy in the treatment of metastatic prostate cancer].
Sakai H; Kanetake H
Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704
[TBL] [Abstract][Full Text] [Related]
15. Total androgen ablation in the treatment of metastatic prostatic cancer. The Canadian Anandron Study Group.
Semin Urol; 1990 Aug; 8(3):159-65. PubMed ID: 2204980
[No Abstract] [Full Text] [Related]
16. Androgen deprivation therapy for prostate cancer: current status and future prospects.
Miyamoto H; Messing EM; Chang C
Prostate; 2004 Dec; 61(4):332-53. PubMed ID: 15389811
[TBL] [Abstract][Full Text] [Related]
17. Advanced prostate cancer. Hormonal treatment.
de la Haba-Rodríguez J
Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
[No Abstract] [Full Text] [Related]
18. Hormone therapy for locally advanced prostate cancer.
Fowler JE; Bigler SA; White PC; Duncan WL
J Urol; 2002 Aug; 168(2):546-9. PubMed ID: 12131306
[TBL] [Abstract][Full Text] [Related]
19. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
20. Total androgen blockade vs orchiectomy in stage D2 prostate cancer.
Béland G; Elhilali M; Fradet Y; Laroche B; Ramsey EW; Venner PM; Tewari HD
Prog Clin Biol Res; 1987; 243A():391-400. PubMed ID: 3116550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
